'Months and months' before large-scale COVID-19 vaccinations can be rolled out
News about the development of a COVID-19 vaccine is encouraging, but it will still be months before it's widely available.
Pfizer and Moderna have released promising results from their vaccine trials, and Massachusetts has submitted a draft plan to the Centers for Disease Control on how a potential COVID vaccine would be distributed.
“As best as we understand, the federal government will be allocating vaccine to the states based on their population,” said Dr. Paul Biddinger, of Massachusetts General Hospital. “What we have heard is, potentially, if there is an emergency use authorized before the end of the year, that Massachusetts could receive hundreds of thousands of doses before the end of the year.”
Biddinger chairs the Massachusetts Vaccine Advisory Group, which was formed to help figure out how to get the vaccine from the factory to the front lines.
There are a number of challenges. Pfizer's vaccine needs to be stored at close to minus 100 degrees Fahrenheit.
“They've engineered special shipping containers that have dry ice and can keep the product for up to 15 days as long as the dry ice is replenished and it isn't opened more than twice a day,” Biddinger said.
Biddinger is optimistic, but he gives a dose of reality.
“People have to understand it will take months and months and months to be able to roll out this scale of vaccination, and we have to vaccinate a large portion of the population before we can roll back the interventions we need right now,” he said.